Interaction between HIV-1 Tat and DNA-PKcs modulates HIV transcription and class switch recombination.
Interaction between HIV-1 Tat and DNA-PKcs modulates HIV transcription and class switch recombination.
复制标题
HIV-I Tat 和 DNA-PKcs 之间的相互作用调节 HIV 转录和类别转换重组
DOI:
10.7150/ijbs.10366
复制
发表时间:
2014
影响因子:
9.2
通讯作者:
Zhou PK
中科院分区:
文献类型:
--
作者:
Zhang SM;Zhang H;Yang TY;Ying TY;Yang PX;Liu XD;Tang SJ;Zhou PK
HIV-1 tat targets a variety of host cell proteins to facilitate viral transcription and disrupts host cellular immunity by inducing lymphocyte apoptosis, but whether it influences humoral immunity remains unclear. Previously, our group demonstrated that tat depresses expression of DNA-PKcs, a critical component of the non-homologous end joining pathway (NHEJ) of DNA double-strand breaks repair, immunoglobulin class switch recombination (CSR) and V(D)J recombination, and sensitizes cells to ionizing radiation. In this study, we demonstrated that HIV-1 Tat down-regulates DNA-PKcs expression by directly binding to the core promoter sequence. In addition, Tat interacts with and activates the kinase activity of DNA-PKcs in a dose-dependent and DNA independent manner. Furthermore, Tat inhibits class switch recombination (CSR) at low concentrations (≤4 µg/ml) and stimulates CSR at high concentrations (≥8 µg/ml). On the other hand, low protein level and high kinase activity of DNA-PKcs promotes HIV-1 transcription, while high protein level and low kinase activity inhibit HIV-1 transcription. Co-immunoprecipitation results revealed that DNA-PKcs forms a large complex comprised of Cyclin T1, CDK9 and Tat via direct interacting with CDK9 and Tat but not Cyclin T1. Taken together, our results provide new clues that Tat regulates host humoral immunity via both transcriptional depression and kinase activation of DNA-PKcs. We also raise the possibility that inhibitors and interventions directed towards DNA-PKcs may inhibit HIV-1 transcription in AIDS patients.
登录
查看更多内容
DOI:
10.1084/jem.20001871
发表时间:
2002-12-02
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bosma GC;Kim J;Urich T;Fath DM;Cotticelli MG;Ruetsch NR;Radic MZ;Bosma MJ
通讯作者:
Bosma MJ
影响因子:
4.8
作者:
Jin, SF;Kharbanda, S;Weaver, DT
通讯作者:
Weaver, DT
影响因子:
5.3
作者:
El Kharroubi, A;Piras, G;Martin, MA
通讯作者:
Martin, MA
DOI:
10.1073/pnas.1308673110
发表时间:
2013-08-13
影响因子:
11.1
作者:
Johnson, Tory P.;Patel, Karan;Nath, Avindra
通讯作者:
Nath, Avindra
DOI:
10.1073/pnas.95.2.525
发表时间:
1998-01-20
影响因子:
11.1
作者:
Hammarsten, O;Chu, G
通讯作者:
Chu, G